XML 23 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net income $ 318,757,352 $ 360,797,232 $ 347,563,621
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 96,568,443 99,112,019 104,739,900
Gain on disposal of assets (70,736) (488,750) (311,510)
Loss on disposal of assets 28,424 230,933 162,553
Gain on sale of investments and equity method investment income (392,040) (1,379,538) (3,163,164)
Loss on sale of investments and equity method investment losses 2,104,907 307,490 1,064,508
Deferred income taxes (17,777,777) (41,694,751) (15,419,722)
Stock based compensation expense related to employee stock options, employee stock purchases and restricted stock 30,228,606 27,421,645 30,797,327
Change in operating assets and liabilities:      
Accounts receivable (26,698,846) 35,135,429 (49,290,457)
Inventories (88,092,828) (89,975,599) 22,725,798
Prepaid expenses and other (28,788,331) (20,241,994) 10,493,993
Accounts payable 37,423,488 7,266,309 (12,854,038)
Accrued liabilities 14,909,867 (14,322,863) 27,982,962
Net cash flows from operating activities 338,200,529 362,167,562 464,491,771
Activity in available-for-sale securities:      
Sales proceeds 37,429,595 56,237,427 24,455,695
Maturities and calls 3,500,000 27,690,000 142,547,368
Purchases (30,107,379) (113,204,199) (73,719,189)
Purchase of equity method investments (33,830,274) 0 0
Plant and equipment additions (146,433,123) (68,835,047) (51,706,541)
Proceeds from sale of plant and equipment 313,917 2,577,855 383,429
Acquisition of businesses, net of cash acquired 0 (12,071,546) (11,216,927)
Increase in other assets (3,611,244) (5,501,445) (4,327,398)
Net cash (used for) from investing activities (172,738,508) (113,106,955) 26,416,437
CASH FLOWS USED FOR FINANCING ACTIVITIES:      
Proceeds from borrowings on Credit Agreement 0 0 75,000,000
Repayment of borrowings on Credit Agreement 0 0 (75,000,000)
Issuance of common stock from stock plan transactions 16,602,274 29,808,787 41,803,640
Cash dividends paid (113,091,921) (115,285,625) (117,181,928)
Repurchases of common stock (112,529,406) (324,643,135) (288,480,506)
Net cash used for financing activities (209,019,053) (410,119,973) (363,858,794)
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH (43,557,032) (161,059,366) 127,049,414
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, Beginning of year 262,311,670 423,371,036 296,321,622
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, End of year $ 218,754,638 $ 262,311,670 $ 423,371,036